216
Participants
Start Date
September 30, 2013
Primary Completion Date
April 20, 2017
Study Completion Date
July 28, 2017
PankoMab-GEX
start dose 500mg at C0D1, maintenance dose 1700mg at CxD1, Number of Cycles: until progression or unacceptable toxicity develops.
Placebo
start dose matching 500mg at C0D1, maintenance dose matching 1700mg at CxD1, Number of Cycles: until progression or unacceptable toxicity develops.
Investigator, Budapest
Investigator, Debrecen
Investigator, Szeged
Investigator, Olsztyn
Investigator, Berlin
Investigator, Lublin
Investigator, Milan
Investigator, Milan
Investigator, Kiel
Investigator, Madrid
Investigator, Madrid
Investigator, Madrid
Investigator, Madrid
Investigator, Madrid
Investigator, Rzeszów
Investigator, Valencia
Investigator, Meldola
Investigator, Poznan
Investigator, Stuttgart
Investigator, Munich
Investigator, Gdansk
Investigator, Munich
Investigator, Bydgoszcz
Investigator, Regensburg
Investigator, Moscow
Investigator, Moscow
Investigator, Moscow
Investigator, Yaroslavl
Investigator, Saint Petersburg
Investigator, Saint Petersburg
Investigator, Saint Petersburg
Investigator, Craiova
Investigator, Timișoara
Investigator, Timișoara
Investigator, Oryol
Investigator, Rostov-on-Don
Investigator, Pyatigorsk
Investigator, Cluj-Napoca
Investigator, Cluj-Napoca
Investigator, Volgograd
Investigator, Oradea
Investigator, Kazan'
Investigator, Brasov
Investigator, Rome
Investigator, Bucharest
Investigator, Barcelona
Investigator, London
Investigator, London
Investigator, Northwood
Investigator, Sutton
Lead Sponsor
Glycotope GmbH
INDUSTRY